HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deletion of Ser-171 causes inactivation, proteasome-mediated degradation and complete deficiency of human transaldolase.

Abstract
Homozygous deletion of three nucleotides coding for Ser-171 (S171) of TAL-H (human transaldolase) has been identified in a female patient with liver cirrhosis. Accumulation of sedoheptulose 7-phosphate raised the possibility of TAL (transaldolase) deficiency in this patient. In the present study, we show that the mutant TAL-H gene was effectively transcribed into mRNA, whereas no expression of the TALDeltaS171 protein or enzyme activity was detected in TALDeltaS171 fibroblasts or lymphoblasts. Unlike wild-type TAL-H-GST fusion protein (where GST stands for glutathione S-transferase), TALDeltaS171-GST was solubilized only in the presence of detergents, suggesting that deletion of Ser-171 caused conformational changes. Recombinant TALDeltaS171 had no enzymic activity. TALDeltaS171 was effectively translated in vitro using rabbit reticulocyte lysates, indicating that the absence of TAL-H protein in TALDeltaS171 fibroblasts and lymphoblasts may be attributed primarily to rapid degradation. Treatment with cell-permeable proteasome inhibitors led to the accumulation of TALDeltaS171 in whole cell lysates and cytosolic extracts of patient lymphoblasts, suggesting that deletion of Ser-171 led to rapid degradation by the proteasome. Although the TALDeltaS171 protein became readily detectable in proteasome inhibitor-treated cells, it displayed no appreciable enzymic activity. The results suggest that deletion of Ser-171 leads to inactivation and proteasome-mediated degradation of TAL-H. Since TAL-H is a regulator of apoptosis signal processing, complete deficiency of TAL-H may be relevant for the pathogenesis of liver cirrhosis.
AuthorsCraig E Grossman, Brian Niland, Christina Stancato, Nanda M Verhoeven, Marjo S Van Der Knaap, Cornelis Jakobs, Lawrence M Brown, Sandor Vajda, Katalin Banki, Andras Perl
JournalThe Biochemical journal (Biochem J) Vol. 382 Issue Pt 2 Pg. 725-31 (Sep 01 2004) ISSN: 1470-8728 [Electronic] England
PMID15115436 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Enzyme Inhibitors
  • Recombinant Proteins
  • Serine
  • RNA
  • Transaldolase
  • Proteasome Endopeptidase Complex
Topics
  • Cells, Cultured
  • Child
  • Enzyme Activation (genetics, physiology)
  • Enzyme Inhibitors (pharmacology)
  • Female
  • Fibroblasts (chemistry, enzymology, metabolism)
  • Gene Expression Regulation, Bacterial (genetics)
  • Gene Expression Regulation, Enzymologic (drug effects, genetics)
  • Humans
  • Liver Cirrhosis (enzymology, genetics)
  • Lymphocytes (chemistry, enzymology, metabolism)
  • Models, Molecular
  • Mutagenesis, Site-Directed (genetics)
  • Proteasome Endopeptidase Complex (genetics, physiology)
  • Protein Conformation
  • RNA (metabolism)
  • Recombinant Proteins (biosynthesis, genetics)
  • Sequence Deletion (genetics, physiology)
  • Serine (genetics, physiology)
  • Transaldolase (biosynthesis, deficiency, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: